Onyx Healthcare Inc. (TPEX:6569)
113.00
+2.00 (1.80%)
Dec 5, 2025, 1:30 PM CST
Onyx Healthcare Market Cap
Onyx Healthcare has a market cap or net worth of 4.41 billion as of December 5, 2025. Its market cap has decreased by -24.78% in one year.
Market Cap
4.41B
Enterprise Value
4.36B
Revenue
1.38B
Ranking
n/a
PE Ratio
33.85
Stock Price
113.00
Market Cap Chart
Since January 15, 2016, Onyx Healthcare's market cap has increased from 1.94B to 4.41B, an increase of 127.99%. That is a compound annual growth rate of 8.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.41B | -25.27% |
| Dec 31, 2024 | 5.91B | 2.52% |
| Dec 29, 2023 | 5.76B | 77.16% |
| Dec 30, 2022 | 3.25B | 2.87% |
| Dec 30, 2021 | 3.16B | -11.58% |
| Dec 31, 2020 | 3.58B | 3.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |